If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
New Product Development » New Product Planning
Download FREE Excerpt
24 Info Graphics
17 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
With so much riding on a new product launch, pharmaceutical organizations are under pressure to deliver effective products in shorter time frames. Leading companies use the New Product Planning (NPP) function to efficiently and effectively navigate the complicated drug development process to the point of a hand-off to product commercialization teams.
This research identifies the structure and roles of NPP groups, detailing the strengths and weaknesses of various NPP organizational structures and how the operational characteristics of the NPP function evolves as a company matures. In addition, the research examines the differences between global and regional NPP roles.
Best Practices, LLC undertook this benchmarking study to provide new product development leaders at pharmaceutical companies with insights into the structures and roles that leading NPP groups are using to strengthen the development process of their organization.
For this research project, Best Practices, LLC engaged 19 new product development leaders from 15 pharmaceutical, biotech, and life sciences companies.
Biopharmaceutical; Pharmaceutical; Medical Device; Biotech; Health Care; Clinical Research; Laboratories; Manufacturing; Consumer Products; Diagnostic
Alkermes; Zydus Cadila; GlaxoSmithKline ; Astellas; Roche; Novartis; Sanofi; Pfizer; Takeda Pharmaceuticals; Cytokinetics; Allergan; Medicago; Bayer; Galderma; Wockhardt